These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12873612)
1. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Kamei J; Miyata S; Morita K; Saitoh A; Takeda H Pharmacol Biochem Behav; 2003 May; 75(2):247-54. PubMed ID: 12873612 [TBL] [Abstract][Full Text] [Related]
2. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test. Miyata S; Hirano S; Kamei J Neuropsychopharmacology; 2004 Mar; 29(3):461-9. PubMed ID: 14628002 [TBL] [Abstract][Full Text] [Related]
3. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. Da-Rocha MA; Puech AJ; Thiébot MH J Psychopharmacol; 1997; 11(3):211-8. PubMed ID: 9305412 [TBL] [Abstract][Full Text] [Related]
4. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786 [TBL] [Abstract][Full Text] [Related]
5. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Rénéric JP; Bouvard M; Stinus L Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533 [TBL] [Abstract][Full Text] [Related]
6. Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test. Fujishiro J; Imanishi T; Baba J; Kosaka K Jpn J Pharmacol; 2001 Mar; 85(3):327-30. PubMed ID: 11325027 [TBL] [Abstract][Full Text] [Related]
7. Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA Benham RS; Hewage NB; Suckow RF; Engin E; Rudolph U Behav Brain Res; 2017 Aug; 332():172-179. PubMed ID: 28587819 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test. Yamada J; Sugimoto Y Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041 [TBL] [Abstract][Full Text] [Related]
9. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507 [TBL] [Abstract][Full Text] [Related]
10. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. Joel D; Ben-Amir E; Doljansky J; Flaisher S Behav Pharmacol; 2004 May; 15(3):241-52. PubMed ID: 15187582 [TBL] [Abstract][Full Text] [Related]
11. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. O'Leary OF; Bechtholt AJ; Crowley JJ; Valentino RJ; Lucki I Eur Neuropsychopharmacol; 2007 Feb; 17(3):215-26. PubMed ID: 16997535 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice. Ago Y; Harasawa T; Itoh S; Nakamura S; Baba A; Matsuda T Eur J Pharmacol; 2005 Sep; 520(1-3):86-90. PubMed ID: 16140294 [TBL] [Abstract][Full Text] [Related]
13. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice. Takeuchi T; Owa T; Nishino T; Kamei C Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. Mayorga AJ; Dalvi A; Page ME; Zimov-Levinson S; Hen R; Lucki I J Pharmacol Exp Ther; 2001 Sep; 298(3):1101-7. PubMed ID: 11504807 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test. Kamei J; Miyata S; Sunohara T; Kamei A; Shimada M; Ohsawa M J Pharmacol Sci; 2008 Nov; 108(3):381-4. PubMed ID: 18987428 [TBL] [Abstract][Full Text] [Related]
16. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Rénéric JP; Bouvard M; Stinus L Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415 [TBL] [Abstract][Full Text] [Related]
17. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice. Koek W; Sandoval TL; Daws LC Behav Pharmacol; 2018 Aug; 29(5):453-456. PubMed ID: 29200003 [TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Artaiz I; Zazpe A; Innerárity A; Del Olmo E; Díaz A; Ruiz-Ortega JA; Castro E; Pena R; Labeaga L; Pazos A; Orjales A Psychopharmacology (Berl); 2005 Nov; 182(3):400-13. PubMed ID: 16032410 [TBL] [Abstract][Full Text] [Related]
20. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. Berrocoso E; Mico JA Int J Neuropsychopharmacol; 2009 Sep; 12(8):1033-44. PubMed ID: 19341511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]